The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

NUVB FINANCIAL STATEMENTS

Nuvation Bio Inc — balance sheet, income statement and cash flow trends

NUVBNuvation Bio Inc

🇺🇸 USA · NYSE · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
-500 M-250 M0202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue169.9 M $Gross Profit159.6 M $ · 94%Operating Income-137.6 M $ · -81%Pre-tax Income-149.8 M $ · -88%Net Income to Owners-149.8 M $ · -88%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue169.9 M $+1,083.6%
Gross Profit159.6 M $+3,936.4%
Operating Income-137.6 M $—
EBITDA-127 M $—
Net Income to Owners-149.8 M $—

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
0250 M500 M750 M202120222023202420252026

Capital Structure

Q2 2026
Total Assets744.5 M
  • Equity253.9 M $34%
  • Current Liabilities86.8 M $12%
  • Long-term Liabilities403.9 M $54%

Key Figures

YoY change
Total Assets744.5 M $+15.0%
Total Liabilities490.6 M $+78.9%
Total Equity253.9 M $-31.9%
Cash & ST Investments661 M $+8.8%
Total Debt252.1 M $+336.5%
Net Debt-6.5 M $—

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-100 M0202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
-100 M-50 M050 M-82.6 M $Operating-47.2 M $Investing179.1 M $Financing49.3 M $Net Change

Key Figures

YoY change
Operating Cash Flow-82.6 M $—
Capital Expenditures197 K $-52.4%
Free Cash Flow-82.7 M $—
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on NUVB

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 11, 26. This content is for informational purposes only and is not investment advice.